Hormone Therapy Near Menopause Linked to Lower Cardiovascular Risk

A new analysis from the Study of Women's Health Across the Nation (SWAN) suggests that hormone therapy initiated around the time of menopause is associated with a 22% lower risk of cardiovascular disease. This observational evidence aims to inform discussions between women and healthcare providers regarding the potential benefits and risks of hormone therapy for symptoms like hot flashes and night sweats.